Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland R Griffiths

Showing results (91-100 of 136) with videos related to

Pageof 14
Sort By:
Psychedelic Medicine (New Rochelle, N.Y.)|March 7, 2025
Impact of Psilocybin on Peripheral Cytokine ProductionDana DiRenzo, Frederick S Barrett, Jamie Perin, et al.
Journal of Psychopharmacology (Oxford, England)|May 16, 2019
Cessation and reduction in alcohol consumption and misuse after psychedelic useAlbert Garcia-Romeu, Alan K Davis, Fire Erowid, et al.
Journal of Psychopharmacology (Oxford, England)|January 11, 2021
Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSDAlan K Davis, Frederick S Barrett, Sara So, et al.
Frontiers in Psychiatry|February 11, 2020
Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online SurveyAlbert Garcia-Romeu, Alan K Davis, Earth Erowid, et al.
Psychopharmacology|June 16, 2011
Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effectsRoland R Griffiths, Matthew W Johnson, William A Richards, et al.
Journal of Psychopharmacology (Oxford, England)|November 19, 2016
The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushroomsFrederick S Barrett, Matthew P Bradstreet, Jeannie-Marie S Leoutsakos, et al.
Psychedelic Medicine (New Rochelle, N.Y.)|December 28, 2023
Double-Blind Comparison of the Two Hallucinogens Dextromethorphan and Psilocybin: Experience-Dependent and Enduring Psychological Effects in Healthy VolunteersDavid S Mathai, Samantha Hilbert, Nathan D Sepeda, et al.
Plos One|August 24, 2022
Comparison of psychedelic and near-death or other non-ordinary experiences in changing attitudes about death and dyingMary M Sweeney, Sandeep Nayak, Ethan S Hurwitz, et al.
Journal of Psychopharmacology (Oxford, England)|April 30, 2020
Survey of entity encounter experiences occasioned by inhaled <i>N,N</i>-dimethyltryptamine: Phenomenology, interpretation, and enduring effectsAlan K Davis, John M Clifton, Eric G Weaver, et al.
Psychopharmacology|April 25, 2012
High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogensChad J Reissig, Lawrence P Carter, Matthew W Johnson, et al.
Pageof 14

Showing results (91-100 of 136) with videos related to

Sort By:
Pageof 14
Psychedelic Medicine (New Rochelle, N.Y.)|March 7, 2025
Impact of Psilocybin on Peripheral Cytokine ProductionDana DiRenzo, Frederick S Barrett, Jamie Perin, et al.
Journal of Psychopharmacology (Oxford, England)|May 16, 2019
Cessation and reduction in alcohol consumption and misuse after psychedelic useAlbert Garcia-Romeu, Alan K Davis, Fire Erowid, et al.
Journal of Psychopharmacology (Oxford, England)|January 11, 2021
Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSDAlan K Davis, Frederick S Barrett, Sara So, et al.
Frontiers in Psychiatry|February 11, 2020
Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online SurveyAlbert Garcia-Romeu, Alan K Davis, Earth Erowid, et al.
Psychopharmacology|June 16, 2011
Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effectsRoland R Griffiths, Matthew W Johnson, William A Richards, et al.
Journal of Psychopharmacology (Oxford, England)|November 19, 2016
The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushroomsFrederick S Barrett, Matthew P Bradstreet, Jeannie-Marie S Leoutsakos, et al.
Psychedelic Medicine (New Rochelle, N.Y.)|December 28, 2023
Double-Blind Comparison of the Two Hallucinogens Dextromethorphan and Psilocybin: Experience-Dependent and Enduring Psychological Effects in Healthy VolunteersDavid S Mathai, Samantha Hilbert, Nathan D Sepeda, et al.
Plos One|August 24, 2022
Comparison of psychedelic and near-death or other non-ordinary experiences in changing attitudes about death and dyingMary M Sweeney, Sandeep Nayak, Ethan S Hurwitz, et al.
Journal of Psychopharmacology (Oxford, England)|April 30, 2020
Survey of entity encounter experiences occasioned by inhaled <i>N,N</i>-dimethyltryptamine: Phenomenology, interpretation, and enduring effectsAlan K Davis, John M Clifton, Eric G Weaver, et al.
Psychopharmacology|April 25, 2012
High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogensChad J Reissig, Lawrence P Carter, Matthew W Johnson, et al.
Pageof 14